Great time to get into this stock with the dip in markets IMO market cap still well below fair value for this company with very promising near term milestones.
There are TWO new FDA approvals all but guaranteed in June - soft tissue and vitiligo. Already awarded accelerated status for approval by FDA. These are much bigger markets.
Remember it was 2018 the last new FDA approval for AVH - which was before the huge run up in price to over $16.
Yes there was a FDA extension for paediatric burns, but as far as new indications it is the first expansion in market in 5 years and is definitely the inflection point for this company as they are now targeting much larger markets and sales will follow as this is a area of unmet need with much better outcomes.
With such huge milestone on the cards very soon it is very likely this is the time to board this train…..
AVH Price at posting:
$3.84 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)